Literature DB >> 15888740

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer.

D Cunningham1, L M Jost, G Purkalne, J Oliveira.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888740     DOI： 10.1093/annonc/mdi812

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

1.  siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells.

Authors:  Xiao-Tong Wang; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

2.  Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo.

Authors:  Xiao Tong Wang; Yu Bo Xie; Qiang Xiao
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

3.  Recommendations on current approach to gastric cancer.

Authors:  Fernando Rivera; Alfredo Carrato; Cristina Grávalos; Carles Pericay; Javier Sastre; Enrique Aranda
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

4.  The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.

Authors:  S T Kim; I-G Do; J Lee; I Sohn; K-M Kim; W K Kang
Journal:  Clin Transl Oncol       Date:  2014-12-02       Impact factor: 3.405

5.  A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?

Authors:  Domenico Ciliberto; Nicoletta Staropoli; Francesca Caglioti; Simona Gualtieri; Lucia Fiorillo; Silvia Chiellino; Antonina Maria De Angelis; Francesco Mendicino; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2015-06-10       Impact factor: 4.742

6.  A phase II study of leucovorin, 5-FU and docetaxel combination chemotherapy in patients with inoperable or postoperative relapsed gastric cancer.

Authors:  Kwang-Sun Lee; Ha-Yeon Lee; Eun-Kyung Park; Joung-Soon Jang; Sang-Jae Lee
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

7.  Use of lectin microarray to differentiate gastric cancer from gastric ulcer.

Authors:  Wei-Li Huang; Yang-Guang Li; Yong-Chen Lv; Xiao-Hui Guan; Hui-Fan Ji; Bao-Rong Chi
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 8.  Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.

Authors:  Rebecca K S Wong; Raymond Jang; Gail Darling
Journal:  J Gastrointest Oncol       Date:  2015-02

9.  Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer.

Authors:  Seung Tae Kim; Hye-Lim Jang; Jeeyun Lee; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Min Gew Choi; Jae Moon Bae; Tae Sung Sohn; Jae Hyung Noh; Sung Kim; Kyoung-Mee Kim; Won Ki Kang; Joon Oh Park
Journal:  Transl Oncol       Date:  2015-08       Impact factor: 4.243

10.  A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.

Authors:  Jeeyun Lee; Sung Kim; Phillip Kim; Xinjun Liu; Tani Lee; Kyoung-Mee Kim; In-Gu Do; Joon Oh Park; Se Hoon Park; Jiryeon Jang; Nicholas Hoe; Gulia Harvie; Anne Kuller; Anjali Jain; Gary Meyer; Glen Leesman; Young Suk Park; Min Gew Choi; Tae Sung Sohn; Jae Moon Bae; Ho Yeong Lim; Sharat Singh; Won Ki Kang
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.